Optimization of Specialty Drug Costs Under the Medical Benefit
To achieve savings, health plans must view a claim payment as an output of the inter-relationships between drug, diagnosis, dosing, unit, and pricing. “Optimization of Specialty Drug Costs Under the Medical Benefit” provides comprehensive details on how a payor can apply modest policy adjustments and some straight-forward network engagement tactics to achieve a 6% to 10% in savings thanks to tighter Medical Drug management controls.
Todd Cooperman, PharmD, MBA, RPh
Senior Vice President, Clinical Insight and Analytics